Search

everythinglearnresearchcommunity

for

Search:↓

Topical minoxidil is not very effective for baldness.

Dermal sheath cells can help grow new hair follicles and show promise in treating hair loss.

Canine dermal papilla cells and fibroblasts have distinct growth patterns and protein expressions.

Hirsutism involves excessive hair growth due to hormonal issues and can be treated with medication or surgery.

The study concluded that hair growth in mice is regulated by a stable interaction between skin cell types, and disrupting this can cause hair loss.

Certain genes influence the direction of hair whorls on the scalp.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The sebaceous gland plays a significant role in hair loss and thinning, and using growth stimulators, DHT inhibitors, anti-inflammatory drugs, anti-androgens, and super oxide dismuse substances can help manage it.

Phosphorylation of certain parts of the PIN3 protein is crucial for its role in plant root growth and response to gravity.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Lower growth factors linked to balding in androgenetic alopecia.

Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.

Acquired alopecia is hair loss that can be reversible or irreversible, depending on whether the hair follicle is destroyed.

More minoxidil applied topically leads to better hair growth in male pattern baldness.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Key genes and factors crucial for hair follicle development and wool traits in Merino sheep were identified.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Micrografts and minigrafts are safe and effective for hair transplantation in facial and scalp reconstruction, providing high patient satisfaction.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The biology of skin and hair is complex and not fully understood.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

FLRG and follistatin have different roles in wound healing.

Human hair follicles contain a complex network of prostanoid receptors that may influence hair growth.

Puberty is driven by hormonal changes, mainly influenced by genetics, nutrition, and body fat.